2024-05-13T10:12:49-07:00 2023-06-30 952076568 Leaf & Cole LLP 2810 Camino Del Rio South Suite 200 San Diego CA 92108 990 2022-07-01 800418281 PROTEOGENOMICS RESEARCH INSTITUTE FOR SYSTEMS MEDICINE PROT 8584509999 PO BOX 910212 SAN DIEGO CA 92191 AMIE FENNELLY DIRECTOR OF FINANCE 2024-05-10 true AMIE FENNELLY 999009999 true JILL BRANCH P00727664 6192947200 X 2 AAL1 IAL1 FAL1 2022 2023-04-26 12:10:37Z JAN E SCHNITZER MD PO BOX 910212 SAN DIEGO CA 92191 6644651 false X WWW.PRISM-SD.ORG X 2009 CA Proteogenomics Research Institute for Systems Medicine (PRISM) is a non-profit biomedical research institute focused on the development of innovative treatments for a wide spectrum of human diseases, including cancer. 4 2 36 0 6503573 6644651 10389 0 0 0 6513962 6644651 0 0 3278193 3386200 0 0 3236720 3283415 6514913 6669615 -951 -24964 604813 1762990 1112068 2295209 -507255 -532219 Proteogenomics Research Institute for Systems Medicine (PRISM) is a non-profit biomedical research institute focused on the development of innovative treatments for a wide spectrum of human diseases, including cancer. false false 5447479 PRISM is focused on the development of innovative treatments for a wide spectrum of human diseases, including cancer. PRISM employs the principles of systems science, an ordered and interdisciplinary approach to study the relationships between healthy and diseased tissues. PRISM's state-of-the-art facilities combine advanced technologies in proteomics, genomics and in vivo imaging to discover and validate novel therapeutic targets. PRISM develops novel molecules and probes which allow dynamic, non-invasive functional imaging of healthy and diseased tissue in vivo. These molecules and probes are the core component of new therapies, which specifically target diseased organs while sparing normal tissues and cells. In this way, PRISM is developing more effective, less toxic treatments that extend life and provide a better quality of life for patients diagnosed with chronic and life-threatening diseases. 5447479 true true false false false false false false false false true false false true true true true false false false false false false false false false false false false true false false false true false false false false false false false false false false false false false true 11 0 true 36 true false false false false false false false 0 false false false false false false false X 4 2 false false false false false false false true false false false true true true true true true true false false CA X L JEAN REMMER 8584509999 505 COAST BLVD SOUTH STE 206 LA JOLLA CA 92037 JAN E SCHNITZER MD President & CEO 40.00 0.00 X X 205573 0 63475 MICHAEL LEVIN DIR NANOTECHNOLOGY 40.00 0.00 132288 0 36221 ADRIAN CHRASTINA ASST. PROFESSOR 40.00 0.00 124668 0 43389 BOGDAN OLENYUK PROFESSOR 40.00 0.00 137550 0 25088 TIMOTHY BUSS SR RESEARCH SCIENT 40.00 0.00 128773 0 27788 L JEAN REMMER Vice President 32.00 0.00 X X 128696 0 15133 Ann FENNELLY DIR OF FINANCES 32.00 0.00 99843 0 11358 JOHN ROUSSIN Director 1.00 0.00 X 0 0 0 EVE DREYFUS MD Director 1.00 0.00 X 0 0 0 957391 222452 6 false true false 0 6644651 6644651 0 0 0 0 0 0 0 0 0 0 6644651 0 0 0 0 337261 158156 179105 0 2175819 1735871 439948 0 670286 509590 160696 202834 151004 51830 0 20029 8404 11625 18600 18600 0 0 0 90884 61849 29035 0 42263 1927 40336 46047 37026 9021 0 988155 774775 213380 13758 4459 9299 0 0 0 0 11655 11655 7354 7354 SUBCONTRACTORS 1054948 1054948 LABORATORY SUPPLIES 476390 476390 EQUIPMENT LEASE 404645 404645 REPAIR AND MAINTENANCE 62074 62032 42 46613 6403 40210 6669615 5447479 1222136 0 82750 60138 0 434468 541430 0 0 0 0 0 15131 19864 58275 43706 26224 14569 0 0 0 0 46240 1126989 604813 1762990 578563 640966 533505 548894 1105349 1112068 2295209 X -507255 -532219 -507255 -532219 604813 1762990 -24964 X false true X true true true X 4546266 5958739 6338383 6503573 6644651 29991612 0 0 4546266 5958739 6338383 6503573 6644651 29991612 0 29991612 42 42 0 0 29991654 294845 1.00000 1.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 58275 43706 14569 14569 DEPOSIT 46240 RIGHT OF USE ASSET 1080749 1126989 OPERATING LEASE LIABILITY 1105349 1105349 X 6644651 6644651 6644651 6669615 6669615 6669615 Part X : FIN48 Footnote The Organization believes that it has appropriate support for any tax positions taken, and as such, does not have any uncertain tax positions that are material to the financial statements. X X false false false false false false false false false ADRIAN CHRASTINA ASST. PROFESSOR 124668 13215 30174 168057 BOGDAN OLENYUK PROFESSOR 137550 14025 11063 162638 JAN E SCHNITZER MD President & CEO 205573 20657 42818 269048 MICHAEL LEVIN DIR NANOTECHNOLOGY 132288 14046 22175 168509 TIMOTHY BUSS SR RESEARCH SCIENT 128773 13513 14275 156561 Dr Schnitzer Officer LOAN X 556655 523894 false true true cavatar llc CEO -100% operating X 25000 25000 false true true 548894 DR SCHNITZER OFFICER 251527 EQUIPMENT LEASE false Form 990, Part VI, Section B, Line 11b The Treasurer reviews the return and submits the return the Board Members to review. Form 990, Part VI, Section B, Line 12c All Board Members and employees review and sign the conflict of interest policy annually. All signed conflict of interest policies are kept on file until the following year when the renewal is required. The renewal is done in January or February and all new employees and new Board Members will sign a conflict of interest policy on the day of hire. Form 990, Part VI, Section B, Line 15a Policy Regarding Determination of Compensation for President and CEO:The PRISM Board of Directors (Board) functions as the Compensation Committee for purposes of determining executive salary comparability and ensuring all of PRISM's compensation practices are carried out in a responsible manner that are also compliant with state and federal regulations. The Board has overall responsibility for evaluating the performance and compensation of the President and CEO (Executive). The Board has responsibility to provide the Executive with constructive feedback regarding his performance. Any changes in salary for the Executive will be determined using the following process:a) The PRISM Board of Directors shall also serve as the Compensation Committee.b) Prior to any change in salary, the Board shall obtain third party benchmark data for positions comparable to that of the Executive to ensure comparability of total compensation.c) After a review of comparability data, the Chair of the Board will make a recommendation of an appropriate salary, bonus and any other fringe benefits or perquisites, subject to approval by the Board.d) The Board will consider any changes to the Executive's salary based on the Executive's performance against expectations and goals, as well as the reasonableness of the recommendation based on the comparability data it has reviewed.e) The Board, by vote, will approve or disapprove the recommended change to Executive's salary. If approved:f) The Chair of the Board or his/her designee will delegate to a PRISM staff member implementation of the resolved compensation and/or benefit changes. Form 990, Part VI, Section C, Line 19 PRISM makes its governing documents, conflict of interest policy and financial statements available to the public upon request. NUMBER OF W2'S FILED Payroll and Benefit services are provided to PRISM by Paychex. W-2s for PRISM employees list PRISM/Paychex as the Employer and the EIN is Paychex's rather than PRISM's. A search of IRS records under PRISM's EIN will not yield the payroll numbers as indicated.